Clicky

MARAVAI LIFESC.HLD.A -01(MAR)

Description: Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.


Keywords: Biotechnology Biopharmaceutical Gene Therapy Molecular Diagnostics Human Diseases Biopharmaceutical Products In Vitro Diagnostics Elisa Drug Therapies Oligonucleotide Chemical Synthesis Biopharmaceutical Development Assay Development Services Analytical Products Biologic Manufacturing Process Development Diagnostic And Therapeutic Applications

Home Page: www.maravai.com

10770 Wateridge Circle
San Diego, CA 92121
United States
Phone: 858 546 0004


Officers

Name Title
Mr. Carl W. Hull Co-Founder & Executive Chairman
Mr. William E. Martin III CEO & Director
Mr. Kevin M. Herde CPA Executive VP & CFO
Dr. Peter Michael Leddy Ph.D. Executive VP & Chief Administrative Officer
Ms. Christine Dolan Executive VP & GM of Cygnus Technologies
Mr. Andrew Burch President of Nucleic Acid Production
Ms. Debra Hart Senior Director of Investor Relations
Mr. Kurt Oreshack J.D. Executive VP, General Counsel & Secretary
Ms. Rebecca Buzzeo Executive VP & Chief Commercial Officer
Dr. Kate E. Broderick Ph.D. Chief Innovation Officer

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 370.3704
Trailing PE: 0
Price-to-Book MRQ: 2.0794
Price-to-Sales TTM: 4.4156
IPO Date:
Fiscal Year End: December
Full Time Employees: 580
Back to stocks